⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
Paradigm Health Announces Collaboration with the FDA to Transform Regulatory Review of Clinical Trial Data
prnewswire.com
AMGN
AZN
Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape
globenewswire.com
UCB
AZN
LLY
PFE
ABBV
REGN
AMGN
BMY
SNY
JNJ
TLRY
Antibody Drug Conjugate Market Turns $13.51 Bn into a $32.66 Bn Opportunity by 2035
globenewswire.com
MRK
BMY
AZN
JNJ
A Call to Action to Help Fight Kidney Failure in At-Risk Communities: American Kidney Fund Urges People to be APOL1 Aware
globenewswire.com
VRTX
AZN
FormBlends Publishes 2026 State of Peptides Report as RFK-Era HHS Signals Major Shifts for GLP-1 and Peptide Therapy Access in the United States
globenewswire.com
LLY
NVO
BMY
AMGN
AZN
PFE
ALT
HERVolution Therapeutics Appoints Dr. László B. Tankó to Scientific Advisory Board to Strengthen Cardiometabolic Clinical Development Strategy
prnewswire.com
AZN
ESR1 Mutated Metastatic Breast Cancer Market Research Report 2026: Epidemiological Analysis, Competitive Landscape, Regulatory Landscape, Pipeline Analysis, M&A, Regulatory Activities, Funding,
globenewswire.com
AZN
BIO
ROG
PFE
Gastroesophageal Adenocarcinoma Market Research Report 2026, Competitive Analysis of ALX Oncology, Merck, AstraZeneca, BeOne Medicines, Taiho Pharmaceuticals, Eli Lilly - Global Forecast to 2035
globenewswire.com
ALXO
MRK
AZN
LLY
AI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive Innovation
globenewswire.com
XAIR
AZN
BMY
PFE
MRK
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
globenewswire.com
MRK
IPHA
VERU
KURA
INCY
AMGN
PFE
GILD
REGN
AZN
CRSP
BIIB
NTRA
ALLO
KYMR
ADCT
IMUX
CELC
ONON
ABBV
TDOC
BMY
IMVT
GNTX
IMPP
AUTL